MIR1227: A Potential Drug Target and Biomarker (G100302283)
MIR1227: A Potential Drug Target and Biomarker
MIR1227, also known as interleukin-12 (IL-12), is a cytokine that plays a crucial role in the regulation of immune responses and inflammation. It is a short cytokine that consists of 122 amino acids and has been shown to have potent immune-modulating effects.
The immune system is a critical component of the body that protects the body against harmful pathogens and diseases. The immune system is composed of various types of cells, including T cells, B cells, and natural killer cells, which work together to detect and respond to foreign substances in the body.
IL-12 is a cytokine that is derived from the T cells. It is a critical factor in the regulation of the immune response, as it helps to promote the growth and activation of T cells. IL-12 has been shown to have a variety of immune-modulating effects, including the regulation of the T cell response to viruses and cancer cells.
One of the most promising aspects of IL-12 is its potential as a drug target. IL-12 has been shown to have a variety of therapeutic effects, including the regulation of inflammation, the promotion of wound healing, and the regulation of pain.
In addition to its potential therapeutic effects, IL-12 has also been shown to be a potential biomarker for a variety of diseases. For example, research has shown that IL-12 levels are often elevated in the blood of individuals with rheumatoid arthritis, a common form of arthritis that causes pain, inflammation, and joint damage.
Furthermore, IL-12 has also been shown to be elevated in the blood of individuals with other inflammatory diseases, such as heart disease, obesity, and diabetes. These findings suggest that IL-12 may be a useful biomarker for the diagnosis and treatment of inflammatory diseases.
In conclusion, MIR1227 is a potential drug target and biomarker that has the potential to revolutionize our understanding of immune responses and inflammation. Further research is needed to fully understand the various therapeutic effects of IL-12 and to develop safe and effective treatments for a variety of diseases.
Protein Name: MicroRNA 1227
More Common Targets
MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127 | MIR1270 | MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5
